
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pseudomyxoma peritonei causes
Introduction
Overview
Overview
Pseudomyxoma peritonei is a rare disease caused by a pre-existing intraperitoneal mucinous neoplasm, accumulation of fluids in abdominal cavity causes mass impact on vital organs such as the spleen, kidney, and pancreas. The pathology and causes of pseudomyxoma peritonei are poorly understood. It is shown in some studies that the K-Ras and p53 genes may be involved in the oncogenesis.
Causes
Causes
- Studies have shown and supported that pseudomyxoma peritonei arises from primary appendiceal neoplasm rather than ovarian or colon.[1]
- The primary tumor appears to arise from the MUC2 expressing goblet cells and most commonly from these cells in the appendix.[2]
- The K-Ras and p53 genes may be involved in the oncogenesis. It was shown in studies that overexpression of p53 was in correlation with female sex, highe-grade disease, and worse survival.[3]
References
References
- ↑ Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, Cecil T, Moran B (October 2012). “Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases”. J. Clin. Pathol. 65 (10): 919–23. doi:10.1136/jclinpath-2012-200843. PMID 22718846.
- ↑ O’Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH (August 2002). “Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells”. Am. J. Pathol. 161 (2): 551–64. doi:10.1016/S0002-9440(10)64211-3. PMID 12163380.
- ↑ Shetty S, Thomas P, Ramanan B, Sharma P, Govindarajan V, Loggie B (March 2013). “Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis”. J. Surg. Res. 180 (1): 97–103. doi:10.1016/j.jss.2012.10.053. PMID 23199549.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]Parminder Dhingra, M.D. [3]
